Login
Novartis NYSE: NVS
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide
| Name | Novartis |
| Ticker | NVS |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
|
Price
52W Low/High |
87.56
70.67 / 98.47 |
| Momentum | Weak Down |
| Market cap | 202 B |
| 1Y Total Return |
-0.10%
Weak |
| 1Y Volatility |
28.65%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide
Details
| Ticker | NVS |
| Name | Novartis |
| ISIN | |
| CUSIP | 66987V109 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | Switzerland |
| Currency | U.S. Dollar |
Share as of 3/3/21
| Close Price | 87.56 |
| 52W Low/High | 70.67 / 98.47 |
| Market cap | 202 B |
| 1Y Total Return |
-0.10%
Weak |
| 1Y Volatility |
28.65%
Low Risk |
| Beta | 0.05 |
| PE (trailing) |
17.30
Below Average |
| 12M Dividends | 13.452 |
| Last Dividend Date | 3/3/20 |
| Dividend Yield | 15.36% |
Fin. Strength
| Net Profit Margin | 24.1% |
| Cash from Op. / Cur. Liabilities | 0.48 |
| Diluted Earnings / Share | 5.06 |
| ROE | 17.5% |
| ROIC | 13.8% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 1.0 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 0.53 |
| in Mils USD |
rolling-year up to December
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Revenue |
48,677
|
46,099
|
43,404
|
49,436
|
50,387
|
53,634
|
|
| Gross Profit |
34,252
|
31,589
|
29,771
|
31,916
|
32,983
|
36,289
|
|
| R&D |
9,402
|
8,489
|
8,389
|
9,039
|
8,935
|
9,086
|
|
| EBITDA |
14,375
|
14,838
|
10,056
|
8,538
|
19,544
|
12,459
|
|
| Operating Income |
7,055
|
6,774
|
6,780
|
6,341
|
6,928
|
9,698
|
|
| Net Income exc. Extra |
11,732
|
12,611
|
7,703
|
6,712
|
17,783
|
10,210
|
|
| per Share | |||||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
5.06
|
5.38
|
3.25
|
2.80
|
7.29
|
4.21
|
|
| Dividend |
13.45
|
2.21
|
2.33
|
2.76
|
2.39
|
2.72
|
|
| Div. Yield (an.) |
14.21%
|
2.57%
|
2.77%
|
3.79%
|
2.77%
|
2.75%
|
|
| Balance Sheet | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Total Assets |
118,370
|
145,563
|
133,079
|
130,124
|
131,556
|
125,387
|
|
| Cash, Eq & Invt ShortTerm |
11,446
|
15,964
|
9,485
|
7,777
|
5,447
|
13,862
|
|
| Total Current Assets |
29,504
|
35,563
|
28,208
|
24,931
|
22,845
|
37,561
|
|
| Total Non-Current Assets |
88,866
|
110,000
|
104,871
|
105,193
|
108,711
|
87,826
|
|
| Intangibles |
55,311
|
74,013
|
61,747
|
62,320
|
65,391
|
53,143
|
|
| Total Liabilities |
62,819
|
66,871
|
58,852
|
55,233
|
54,434
|
54,543
|
|
| Total Current Liabilities |
28,264
|
29,607
|
23,403
|
22,209
|
23,708
|
26,973
|
|
| Long Term Debt |
34,555
|
37,264
|
35,449
|
33,024
|
30,726
|
27,570
|
|
| Shareholder equity |
55,474
|
78,614
|
74,168
|
74,832
|
77,046
|
70,766
|
|
| Cash Flow | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Cash from Operations |
13,625
|
14,272
|
12,621
|
11,475
|
11,897
|
13,897
|
|
| Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing |
-2,226
|
-5,591
|
-3,119
|
-3,441
|
-10,784
|
881
|
|
| Capex |
522
|
1,152
|
1,234
|
1,701
|
2,130
|
2,564
|
|
| Cash from Financing |
-13,627
|
-4,244
|
-7,733
|
-5,314
|
-9,176
|
-8,147
|
|
| Stock Issued |
-5,332
|
-1,336
|
-5,238
|
-895
|
-4,490
|
-4,515
|
|
| Debt (LT) Issued |
-4,957
|
4,177
|
4,101
|
2,055
|
1,961
|
3,318
|
|
| Free Cash Flow |
11,541
|
17,070
|
6,044
|
2,451
|
17,552
|
10,159
|
|
| Ratios | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Net Profit Margin |
24.1%
|
27.4%
|
17.7%
|
13.6%
|
35.3%
|
19.0%
|
|
| NCFO / Op.Income |
193.1%
|
210.7%
|
186.2%
|
181.0%
|
171.7%
|
143.3%
|
|
| Current Ratio |
1.0
|
1.2
|
1.2
|
1.1
|
1.0
|
1.4
|
|
| Financial Leverage D/E |
0.53
|
0.41
|
0.38
|
0.32
|
0.28
|
0.29
|
|
| Return on Capital Avg |
13.8%
|
12.6%
|
7.9%
|
7.9%
|
18.8%
|
12.1%
|
|
| Return on Shareholder Equity |
17.5%
|
16.5%
|
10.3%
|
8.8%
|
24.1%
|
14.1%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available